Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.15 USD | -1.57% | +8.12% | +16.75% |
05-07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
05-07 | Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.75% | 5.49B | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.17% | 22.25B | |
-13.14% | 22.09B | |
-7.73% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.
- Sector Update: Health Care Stocks Drifting Away from Wednesday Session Highs